Filing Details
- Accession Number:
- 0001562180-24-006658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-04 20:36:04
- Reporting Period:
- 2024-09-01
- Accepted Time:
- 2024-09-04 20:36:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1568651 | Oscar Health Inc. | OSCR | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1667819 | C. Alessandrea Quane | 75 Varick Street, 5Th Floor New York NY 10013 | Evp, Chief Insurance Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-09-01 | 7,016 | $0.00 | 258,152 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-09-01 | 34,380 | $0.00 | 292,532 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-09-01 | 224,503 | $0.00 | 517,035 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2024-09-01 | 8,652 | $0.00 | 525,687 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-09-03 | 77,181 | $17.99 | 448,506 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-09-04 | 38,740 | $17.46 | 409,766 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-09-04 | 31,616 | $17.85 | 378,150 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Restricted Stock Units | Disposition | 2024-09-01 | 7,016 | $0.00 | 7,016 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2024-09-01 | 34,380 | $0.00 | 34,380 | $0.00 |
| Class A Common Stock | Restricted Stock Units | Disposition | 2024-09-01 | 8,652 | $0.00 | 8,652 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,063 | No | 4 | M | Direct | ||
| 343,796 | No | 4 | M | Direct | ||
| 86,525 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 76,857 | Indirect | Alessandrea C Quane 2024 GRAT |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- The Issuer previously granted the Reporting Person an award of 224,503 restricted stock units that vested on September 1, 2024, following the Talent & Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
- The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
- The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
- The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.
Billionaire Hedge Funds
